• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌缺血:从疾病到综合征。

Myocardial ischemia: From disease to syndrome.

作者信息

Marzilli Mario, Crea Filippo, Morrone Doralisa, Bonow Robert O, Brown David L, Camici Paolo G, Chilian William M, DeMaria Anthony, Guarini Giacinta, Huqi Alda, Merz C Noel Bairey, Pepine Carl, Scali Maria Chiara, Weintraub William S, Boden William E

机构信息

Department of Surgery, Medical, Molecular and Critical Area Pathology, University of Pisa, Italy.

Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Int J Cardiol. 2020 Sep 1;314:32-35. doi: 10.1016/j.ijcard.2020.04.074. Epub 2020 Apr 26.

DOI:10.1016/j.ijcard.2020.04.074
PMID:32348810
Abstract

Although current guidelines on the management of stable coronary artery disease acknowledge that multiple mechanisms may precipitate myocardial ischemia, recommended diagnostic, prognostic and therapeutic algorithms are still focused on obstructive epicardial atherosclerotic lesions, and little progress has been made in identifying management strategies for non-atherosclerotic causes of myocardial ischemia. The purpose of this consensus paper is three-fold: 1) to marshal scientific evidence that obstructive atherosclerosis can co-exist with other mechanisms of ischemic heart disease (IHD); 2) to explore how the awareness of multiple precipitating mechanisms could impact on pre-test probability, provocative test results and treatment strategies; and 3) to stimulate a more comprehensive approach to chronic myocardial ischemic syndromes, consistent with the new understanding of this condition.

摘要

尽管当前关于稳定型冠状动脉疾病管理的指南承认多种机制可能引发心肌缺血,但推荐的诊断、预后和治疗算法仍聚焦于阻塞性心外膜动脉粥样硬化病变,在确定非动脉粥样硬化性心肌缺血病因的管理策略方面进展甚微。本共识文件的目的有三个:1)整理科学证据,证明阻塞性动脉粥样硬化可与其他缺血性心脏病(IHD)机制共存;2)探讨认识多种诱发机制如何影响检测前概率、激发试验结果和治疗策略;3)激发对慢性心肌缺血综合征采取更全面方法,与对该病症的新认识相一致。

相似文献

1
Myocardial ischemia: From disease to syndrome.心肌缺血:从疾病到综合征。
Int J Cardiol. 2020 Sep 1;314:32-35. doi: 10.1016/j.ijcard.2020.04.074. Epub 2020 Apr 26.
2
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!阻塞性冠状动脉粥样硬化与缺血性心脏病:难以捉摸的关联!
J Am Coll Cardiol. 2012 Sep 11;60(11):951-6. doi: 10.1016/j.jacc.2012.02.082.
3
A focus on the prognosis and management of ischemic heart disease in patients without evidence of obstructive coronary artery disease.关注无阻塞性冠状动脉疾病证据患者的缺血性心脏病预后及管理。
Expert Rev Cardiovasc Ther. 2015;13(9):1031-44. doi: 10.1586/14779072.2015.1077114. Epub 2015 Aug 7.
4
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
5
Reappraisal of Ischemic Heart Disease.缺血性心脏病再评估。
Circulation. 2018 Oct 2;138(14):1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373.
6
Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?微血管性冠状动脉功能障碍与缺血性心脏病:2014年我们处于什么阶段?
Trends Cardiovasc Med. 2015 Feb;25(2):98-103. doi: 10.1016/j.tcm.2014.09.013. Epub 2014 Nov 7.
7
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.心肌缺血综合征:一种新的命名法,旨在协调不断发展的国际临床实践指南。
Eur Heart J. 2024 Sep 29;45(36):3701-3706. doi: 10.1093/eurheartj/ehae278.
8
Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests.不伴有阻塞性冠状动脉疾病的心绞痛和心肌缺血:诊断检测的实用考虑。
JACC Cardiovasc Interv. 2014 May;7(5):453-63. doi: 10.1016/j.jcin.2014.01.157. Epub 2014 Apr 16.
9
Spectrum of Ischemic Heart Disease Throughout a Woman's Life Cycle.女性生命周期中心脏缺血性疾病的范围。
Methodist Debakey Cardiovasc J. 2024 Mar 14;20(2):81-93. doi: 10.14797/mdcvj.1331. eCollection 2024.
10
Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications.冠状动脉激发试验在导管室中的应用:病理生理学基础、方法学考虑因素及临床意义。
Atherosclerosis. 2021 Feb;318:14-21. doi: 10.1016/j.atherosclerosis.2020.12.008. Epub 2020 Dec 13.

引用本文的文献

1
Sevoflurane Suppresses Cardiomyocyte Pyroptosis in Myocardial Ischemia via NLRP3 Inflammasome Signaling.七氟醚通过NLRP3炎性小体信号通路抑制心肌缺血中的心肌细胞焦亡
Anal Cell Pathol (Amst). 2025 Aug 24;2025:7119597. doi: 10.1155/ancp/7119597. eCollection 2025.
2
Long-Term Outcomes of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention of Moderate Lesions in Patients with Chronic Coronary Syndrome.慢性冠状动脉综合征患者中度病变经皮冠状动脉介入治疗中血流储备分数指导的长期预后
J Tehran Heart Cent. 2024 Jan;19(1):54-59. doi: 10.18502/jthc.v19i1.15538.
3
Integration of virtual screening and proteomics reveals potential targets and pathways for ginsenoside Rg against myocardial ischemia.
虚拟筛选与蛋白质组学相结合揭示了人参皂苷Rg抗心肌缺血的潜在靶点和途径。
J Ginseng Res. 2024 Jul;48(4):395-404. doi: 10.1016/j.jgr.2024.02.001. Epub 2024 Feb 22.
4
The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways.微小 RNA 调节缺血/再灌注炎症途径中免疫反应的能力。
Genes Immun. 2024 Aug;25(4):277-296. doi: 10.1038/s41435-024-00283-6. Epub 2024 Jun 22.
5
Network Pharmacology and Experimental Validation to Explore Mechanism of Tetrahydropalmatine on Acute Myocardial Ischemia.网络药理学与实验验证探索延胡索乙素治疗急性心肌缺血的作用机制。
Chin J Integr Med. 2023 Dec;29(12):1087-1098. doi: 10.1007/s11655-023-3644-x. Epub 2023 Aug 22.
6
Postoperative Hyperuricemia-A Risk Factor in Elective Cardiosurgical Patients.术后高尿酸血症——择期心脏手术患者的一个危险因素
Metabolites. 2023 Apr 25;13(5):590. doi: 10.3390/metabo13050590.
7
Single-cell and spatial transcriptomics: Advances in heart development and disease applications.单细胞和空间转录组学:心脏发育与疾病应用的进展
Comput Struct Biotechnol J. 2023 Apr 12;21:2717-2731. doi: 10.1016/j.csbj.2023.04.007. eCollection 2023.
8
Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review.中药对心肌缺血再灌注损伤影响的研究进展:综述
Front Pharmacol. 2022 Dec 6;13:1055248. doi: 10.3389/fphar.2022.1055248. eCollection 2022.
9
A Synergistic Effect between Plasma Dickkopf-1 and Obstructive Coronary Artery Disease on the Prediction of Major Adverse Cardiac Events in Patients with Angina: An Observational Study.血浆 Dickkopf-1 与阻塞性冠状动脉疾病对心绞痛患者主要不良心脏事件预测的协同作用:一项观察性研究。
Biomolecules. 2022 Oct 2;12(10):1408. doi: 10.3390/biom12101408.
10
Application of Model-Building Based on Arterial Ultrasound Imaging Evaluation to Predict CHD Risk.基于动脉超声成像评估的模型构建在预测 CHD 风险中的应用。
Comput Math Methods Med. 2022 Sep 19;2022:4615802. doi: 10.1155/2022/4615802. eCollection 2022.